z-logo
Premium
Expanding the Phenotype and Genetic Defects Associated with the GOSR 2 Gene
Author(s) -
Praschberger Roman,
Balint Bettina,
Mencacci Niccolo E.,
Hersheson Joshua,
RubioAgusti Ignacio,
Kullmann Dimitri M.,
Bettencourt Conceição,
Bhatia Kailash,
Houlden Henry
Publication year - 2015
Publication title -
movement disorders clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.754
H-Index - 18
ISSN - 2330-1619
DOI - 10.1002/mdc3.12190
Subject(s) - progressive myoclonus epilepsy , myoclonus , epilepsy , missense mutation , ataxia , medicine , allele , mutation , genotype , lafora disease , disease , genetics , gene , biology , psychiatry , phosphorylation , phosphatase
Background The homozygous missense mutation c.430G>T (p.G144W) in the GOSR 2 gene has been repeatedly shown to cause progressive myoclonus epilepsy/ataxia. Thus far, no other disease associated GOSR 2 mutation has been reported. Methods From epilepsy, movement disorder and genetic clinics 43 patients suffering from progressive myoclonus epilepsy/ataxia were screened for defects in GOSR 2, SCARB 2 and CSTB . Results A 61‐year‐old female patient suffering from progressive myoclonus epilepsy was found to be compound heterozygous for the known c.430G>T and a novel c.491_493del AGA (p.K164del) GOSR 2 mutation. This is so far the oldest GOSR 2 patient and her disease course seems overall milder. Conclusions This finding further highlights the GOSR 2 gene as a cause of progressive myoclonus epilepsy and expands the genotype for a potentially weaker disease allele.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom